TIP811: OTC Markets (OTCM): A Picks and Shovels Play in Modern Capital Markets w/ Kyle Grieve & Shawn O'Malley

Episode Summary

Executive Summary: The episode examines OTC Markets Group as a highly profitable, capital-light market infrastructure business that monetizes OTC trading, issuer listings, and market data. Hosts argue it has strong pricing power, network effects, and regulatory barriers, but also meaningful regulatory risk if rules change. They conclude it is a quality compounder, yet one whose future depends on maintaining its niche and continuing price increases rather than heavy reinvestment.

Main Topics: OTC Markets' business model and segments (Priority: 5/5): The discussion breaks OTC Markets into three core revenue streams: OTC Link trading infrastructure, corporate services for issuers, and market data licensing. Each segment monetizes a different part of the OTC ecosystem and together creates a toll-bridge-like platform for accessing U.S. capital markets. Financial performance and operating leverage (Priority: 5/5): The hosts emphasize OTCM's decade-long double-digit growth in revenue, profits, and free cash flow, achieved with minimal share dilution and no debt. They attribute its superior free cash flow growth to operating leverage and a capital-light structure. Competitive advantages and pricing power (Priority: 5/5): OTCM is presented as a quasi-monopoly with durable advantages from regulatory acceptance, network effects, switching costs, and data ownership. Its ability to raise fees in corporate services and market data shows real pricing power. Regulatory risk and existential threats (Priority: 5/5): The largest risk is regulatory change. If the SEC allows national exchanges to list non-SEC-registered issuers or creates a venture-exchange framework, OTCM's moat and revenue could be materially impaired. Capital allocation and reinvestment limits (Priority: 4/5): OTCM generates very high returns on capital but has limited reinvestment opportunities, so most profits are returned via dividends and modest buybacks. Its growth depends more on price increases and modest acquisitions than on large internal reinvestment. Management quality and incentives (Priority: 4/5): CEO Cromwell Coulson is portrayed as a long-term, transparent steward with significant ownership and aligned incentives. His compensation is modest relative to peers, and the team is rewarded for operating earnings and sustainable revenue growth. Valuation and investment case (Priority: 4/5): The hosts estimate OTCM could compound into a materially higher valuation over five years, but they are cautious because of regulatory uncertainty. They suggest a small starter position unless the multiple falls below 20x earnings.

Key Arguments: OTCM is a critical but underappreciated toll collector in U.S. capital markets, serving securities that cannot or do not list on NYSE/NASDAQ. The company has compounded revenue, profits, and FCF at double-digit rates for a decade without meaningful dilution or debt. OTC Link, corporate services, and market data licensing each benefit from recurring revenue and, in different ways, sticky demand. Pricing power is visible in fee increases for issuer listings and data subscriptions, supporting the thesis that the business has durable value. The strongest moat components are regulatory acceptance, network effects from proprietary data, and switching costs for broker-dealers and issuers. The biggest risk is not competition in the ordinary sense, but regulatory regime change that could open the market to direct exchange competition. OTCM is capital-light and has high returns on equity, but it cannot endlessly reinvest at those rates, so returns depend heavily on dividends and selective M&A. Management appears shareholder-friendly and long-term oriented, with substantial insider ownership and relatively modest pay versus exchange peers. A reasonable base case is continued low-double-digit growth and a higher future value, but the investment is better suited to a small position until valuation and regulatory clarity improve.

Data Points: Securities covered: 12,000+ - OTC Markets platform coverage described as larger than NYSE and NASDAQ combined Employees: fewer than 130 - Company is portrayed as running a large market infrastructure operation with a very small staff 10-year revenue CAGR: 11% - Reported decade-long compounded revenue growth 10-year profit CAGR: 13% - Reported decade-long compounded profits growth 10-year free cash flow CAGR: 14% - Reported decade-long compounded free cash flow growth Share count change over decade: 11.1 million to 11.8 million - Minimal dilution over roughly ten years Debt: zero since 2016 - Company has operated without debt funding for years Gross margin: nearly 60% - Illustrates capital-light, high-margin business profile Operating margin: 34% - Operating profitability cited as higher than Alphabet's operating margin in the discussion OTC Link share of revenue: about 21% / $26 million - Trading infrastructure segment contribution Market data licensing share of revenue: about 40% / $40 million - Data segment contribution Corporate services share of revenue: about 39% / $49 million - Issuer listing and compliance services contribution OTC Link daily transactions in 2021: 48,000 - Explained as a surge from 11,500 daily transactions in 2020 OTC Link daily transactions in 2020: 11,500 - Base year before 2021 spike OTC Link subscriber count: 116 to 77 - Subscriber decline over the last decade in ATS, cited as a potential issue Corporate services retention: 90% to 95% - Renewal rates for OTCQB and OTCQX issuers OTCQX annual fee growth: $15,000 pre-2017 to $23,000 in 2021, then 3%-5% annual increases - Example of pricing power in issuer services Market data revenue growth in 2025: 15% - Attributed to price increases for professional and non-professional user licenses Non-professional user reduction in one year: 18% - A retail-focused broker-dealer policy change reduced reported users materially Top customer concentration in market data licensing: 9% of segment revenue - Latest earnings disclosure for market data segment concentration Revenue per employee: $666,000 in 2020 to $961,000 today - Used to illustrate operating leverage as revenue nearly doubled while headcount rose modestly Transaction-based expenses in 2025: just under 9% of net revenue - Variable costs tied to trading volume and liquidity activity Marketing and advertising spend in 2025: $1.6 million - Used to argue low customer acquisition cost New corporate service subscriptions added in 2025: 430+ - Illustrates issuer acquisition pace Estimated issuer acquisition cost: about $3,700 each - Derived by dividing marketing spend by new issuer adds, with caveats Corporate services churn: 5% to 7% - Supports high lifetime value and sticky revenue Issuer tenure: 14 to 20 years - Average life of corporate services customers Lifetime value per corporate services customer: $350,000 to $500,000 - Estimated from fees and tenure, excluding price increases 2025 customer prepayments: $33.6 million - Used to describe negative working capital and customer-funded financing 2025 ROE: 102% - Reported as unusually high but partly distorted by negative working capital and stock-based comp Cromwell Coulson ownership: over 27% - CEO direct ownership as of 2026 Coulson family ownership: roughly 35% total - Includes additional family holdings beyond the CEO CEO compensation: about $800,000 - Compared with much higher pay at exchange peers Performance hurdle outcome: 2025 and 2024 hurdles not met - Noted in the 2025 annual report Intrinsic value estimate: about $113 per share in 2030 - Based on projected $55 million net income and a 25x multiple Current share price used: $54 - Basis for IRR estimate at time of recording Estimated IRR: about 16% plus 4% dividend yield - Projected return from base-case valuation Current market cap context: hundreds of millions - Market cap described as surprisingly low relative to business quality

Pivotal Quotes: "When you have a monopoly, you can raise prices. It's as simple as that." — Peter Thiel: Closing quote used to frame OTCM's pricing power and moat "OTCM is very much a picks and shovels company for investing in the growth of equity markets in aggregate." — Kyle Grieve: Used to explain why OTC Markets can be viewed as infrastructure rather than a speculative stock picker "Rule number one of investing is to never lose money. And rule number two is to never forget rule number one." — Sean O’Malley: Referenced when discussing downside risk, valuation discipline, and regulatory uncertainty

Implications: OTCM looks like a high-quality, capital-light compounder with strong pricing power, but its moat is unusually dependent on regulation. For investors, that means attractive economics paired with policy risk; for the industry, it shows how infrastructure businesses can quietly capture value without being obvious consumer brands.